A detailed history of Kbc Group Nv transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Kbc Group Nv holds 1,273 shares of ANIP stock, worth $74,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,273
Previous 673 89.15%
Holding current value
$74,037
Previous $40,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$53.35 - $61.74 $32,010 - $37,044
600 Added 89.15%
1,273 $70,000
Q4 2023

Feb 13, 2024

SELL
$48.72 - $65.43 $19,877 - $26,695
-408 Reduced 37.74%
673 $37,000
Q3 2023

Feb 15, 2024

SELL
$50.28 - $64.61 $20,514 - $26,360
-408 Reduced 37.74%
673 $39,000
Q3 2022

Feb 15, 2024

BUY
$29.83 - $38.01 $12,170 - $15,508
408 Added 60.62%
1,081 $35,000
Q2 2022

Feb 14, 2024

BUY
$23.09 - $33.46 $9,420 - $13,651
408 Added 60.62%
1,081 $32,000
Q2 2022

Jul 26, 2022

BUY
$23.09 - $33.46 $24,960 - $36,170
1,081 New
1,081 $32,000
Q1 2020

May 04, 2020

SELL
$30.35 - $67.14 $516,132 - $1.14 Million
-17,006 Closed
0 $0
Q2 2019

Jul 30, 2019

SELL
$67.77 - $82.2 $87,423 - $106,038
-1,290 Reduced 7.05%
17,006 $0
Q1 2019

May 10, 2019

SELL
$45.83 - $70.54 $180,111 - $277,222
-3,930 Reduced 17.68%
18,296 $0
Q4 2018

Jan 31, 2019

SELL
$41.17 - $56.44 $277,115 - $379,897
-6,731 Reduced 23.24%
22,226 $1 Million
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $455,264 - $613,381
8,598 Added 42.23%
28,957 $0
Q2 2018

Aug 03, 2018

BUY
$56.38 - $68.08 $242,546 - $292,880
4,302 Added 26.79%
20,359 $0
Q3 2017

Nov 13, 2017

BUY
$43.46 - $52.49 $697,837 - $842,831
16,057
16,057 $0

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.01B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.